Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma ...

In the past two decades, global spending on health has doubled. Yet, optimal healthcare remains out of reach for most of the world as many countries continue to struggle with the burden of disease ...

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times ...

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and ...

The term "digital twins" has its origins in engineering and computer science, where it refers to a virtual replica of a physical object or system. Simply put, it is a sophisticated, dynamic, real ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these ...

Over the last 25 years, patient advocacy groups (PAGs) have evolved from being optional participants to more formalised, structured, accepted members of the healthcare and research ecosystem.

In our patients focus month, we speak with Graeme Duncan of Healthcare at Home Ltd on the benefits that home healthcare can bring to patients. Home healthcare is the fastest growing sector in the ...

After months of speculation around how Amazon will enter the healthcare market, the home delivery giant announced the acquisition of pharma startup PillPack, causing more traditional pharmacies ...

After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second round to fund the development of ...

Astellas is ready to launch its first digital health offering in the US, a toolkit dedicated to providing at-home monitoring for people living with heart failure. Called Digitiva, it combines Eko ...